BAT5906 injection

DRUG3 trials

Sponsors

Bio-Thera Solutions

Conditions

Age-related Macular DegenerationDiabetic Macular Edema (DME)Neovascular (Wet) Age-related Macular Degeneration

Phase 1

A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration

CompletedNCT04151212

Bio-Thera SolutionsAge-related Macular Degeneration

Start: 2018-10-30End: 2021-04-30Updated: 2021-09-23

Phase 3

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

CompletedNCT05439629

Bio-Thera SolutionsNeovascular (Wet) Age-related Macular Degeneration

Start: 2022-07-07End: 2025-04-22Updated: 2025-12-08

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema

RecruitingNCT07515079

Bio-Thera SolutionsDiabetic Macular Edema (DME)

Start: 2024-10-09End: 2027-04-30Target: 406Updated: 2026-04-07